- Home
- PPBT vs FGI Comparison
PPBT vs FGI Comparison
Compare PPBT & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- FGI
- Stock Information
- Founded
- PPBT 2010
- FGI 1987
- Country
- PPBT Israel
- FGI United States
- Employees
- PPBT N/A
- FGI N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- FGI Industrial Specialties
- Sector
- PPBT Health Care
- FGI Industrials
- Exchange
- PPBT Nasdaq
- FGI Nasdaq
- Market Cap
- PPBT 6.3M
- FGI 5.1M
- IPO Year
- PPBT N/A
- FGI 2022
- Fundamental
- Price
- PPBT $2.62
- FGI $0.72
- Analyst Decision
- PPBT Strong Buy
- FGI
- Analyst Count
- PPBT 1
- FGI 0
- Target Price
- PPBT $33.00
- FGI N/A
- AVG Volume (30 Days)
- PPBT 30.8K
- FGI 403.7K
- Earning Date
- PPBT 05-21-2025
- FGI 05-13-2025
- Dividend Yield
- PPBT N/A
- FGI N/A
- EPS Growth
- PPBT N/A
- FGI N/A
- EPS
- PPBT N/A
- FGI N/A
- Revenue
- PPBT N/A
- FGI $134,277,102.00
- Revenue This Year
- PPBT N/A
- FGI $7.72
- Revenue Next Year
- PPBT N/A
- FGI $6.94
- P/E Ratio
- PPBT N/A
- FGI N/A
- Revenue Growth
- PPBT N/A
- FGI 11.13
- 52 Week Low
- PPBT $2.00
- FGI $0.46
- 52 Week High
- PPBT $13.95
- FGI $1.36
- Technical
- Relative Strength Index (RSI)
- PPBT 56.64
- FGI 62.57
- Support Level
- PPBT $2.46
- FGI $0.67
- Resistance Level
- PPBT $2.80
- FGI $0.90
- Average True Range (ATR)
- PPBT 0.20
- FGI 0.07
- MACD
- PPBT 0.04
- FGI 0.02
- Stochastic Oscillator
- PPBT 66.96
- FGI 54.39
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.